How past Endpoints 11 winners fared as the biotech industry rebounded

Endpoints News reviews 77 E11 startups; highlights include Candid Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in vivo therapies Drug pricing and the IRA: Tracking the government's negotiation…

Kyle LaHucik · 2026-09-10

We'll be unveiling this year's Endpoints 11 in Boston on the night of Sept. 24. Join us. The biopharma industry feels much different than it did in 2018, when Endpoints News ...

Source: Endpoints News